Fisher Scientific International Inc
Fisher Scientific International — Merger or Acquisition (May 2006)
23 slides from Fisher Scientific International's merger presentation, May 8, 2006
Slide 1: Creating the Global Leader in the Life, Laboratory and Health Sciences Industry
Creating the Global Leader in the Life, Laboratory and Health Sciences Industry May 8, 2006
Slide 2: Safe harbor and non-GAAP disclosures
van Lakin Semerts ; sancand utter _ ot Safe haborprovblons anda’ the fivate Securbes Unpaten Retorn Rad 1095. Porare Gating stacmerca wich nvave aur of iacsond enemas. ‘emo Beton and Fisher Slt auton readers tha any fran looking rion neg quaaree jure peomgne and that auairesuts coud hertaeraly Yon t
Slide 3: Fisher Scientific International Inc.
Fisher Scientific International Inc. Industry transforming Exciting growth opportunities World-class capabilities Compelling financial benefits Accelerates Earnings Growth
Slide 4: Industry Dynamics and Thermo Fisher Solutions
Industry Dynamics Thermo Fisher Solutions Accelerating Drug Discovery Broad Product Offering Pressure to Reduce Costs = Extensive Suite of Services Globalization integrated Solutions Regulatory Complexity Global Capabilities Only End-to-End Solutions Provider
Slide 5: Exciting Growth Opportunities
Exciting Growth Opportunities « Expanded market access * Expanded products and services offering « Acquisition opportunities Tremendous Upside for Shareholders Scientific
Slide 6: Experienced management team
« Experienced management team « Unparalleled sales and marketing footprint + Extensive R&D capabilities + Global scale + Demonstrated shareholder value creation Proven Track Record of Success
Slide 7: 20%+ compound growth in adjusted EPS
20%+ compound growth in adjusted EPS 18% accretive to 2007 adjusted EPS $200 million of synergies Over $1 billion of operating cash flow Tremendous Upside for Shareholders
Slide 8: Driving Growth at All Levels
* Complete tool set of customer solutions * Expands reach into high-growth markets and geographies * Unparalleled customer access * Complementary world-class technologies * Opportunity to enhance integrated laboratory workflow solutions * Extensive offering of laboratory support services Driving Gro
Slide 9: Positioned for Growth
Consumables Instrumentation, 28% + $9bn revenues Scale + 350,000 customers + 150 countries + Broad product & service offering + Global capabilities + World class technologies Capabilities + 150 years of combined experience + Proven management team Experience + Pre-eminent product Brand Equity "joa P
Slide 10: Exciting Growth Opportunities
+ Drug Discovery Healtheare + Proteomics Research 19% Life Science + Pharma Services + Molecular Diagnostics + Immunohistochemistry Industrial? . Environmental + Environmental Regulatory Compliance Exciting Growth Opportunities op: 20058 70 fra eves er Bin comgeny as.
Slide 11: Combination Enhances Workflow Capabilities
Laboratory Ser S _.-» ConsumablesiReagent Data Sample Sample Interpretation Preparation Analysis & Storage ‘On| Combination Enhances Workflow Capabilities
Slide 12: Biomarker Research Application
Biomarker Research Application Sample Preparation Complementary Reagents & Consumables Biomarker d ii Identified y y Sample Analysis “=, (Data iterpretation & Storage
Slide 13: Positioned to Capitalize on Increased Services Demand
Laboratory Services + Asset management + Regulatory compliance and validation + Equipment maintenance and applications development Biopharma Services + Managed R&D services + Clinical trial materials management Eee + Biological specimen management + Diagnostic product formulation pe waa Positioned t
Slide 14: Unmatched Global Capabilities
Strong presence in China — Manufacturing capabilities — State-of-the-art demo jab — Over 800 employees Active sourcing network Extensive commercial capabilities — Direct sales/services — Key account focus Clinical trials support in India Unmatched Global Capabilities aE WETTER pe wwe compeny sae.
Slide 15: Superior Capabilities to Accelerate Growth
* 350,000 Customers Served pecialists * 150 Countries Served 2,900 Sales Generalists * Leading Brand Names * Superior e-Commerce Platform 7,500 Sales Representatives Superior Capabilities to Accelerate Growth
Slide 16: Revenue Upside Opportunities
Revenue Upside Opportunities * Integrated Solutions * Life Science Research / Healthcare Convergence * Emerging Markets industry Leadership Driving Upside Growth
Slide 17: $150 Million Cost Savings
$150 Million Cost Savings + Rationalize manufacturing operations + Leverage combined purchasing power + Consolidate administrative activities $50 Million Revenue Opportunities + Cross-selling + Enhanced geographic reach + Penetration of new and existing markets + New solutions development At least $
Slide 18: Transaction Overview
Transaction Overview
Slide 19: Transaction Terms
Transaction Terms Purchase Consideration: 2.00 Thermo shares for each Fisher share Pro Forma Ownership: Thermo 39% Fisher: 61% Board Composition: Chairman of the Board: Paul Meister Thermo: 5 Directors Fisher: 3 Directors Management Chief Executive Officer: Mariin Dekkers Headquarters: Waltham, Mass
Slide 20: 2007 Financial Expectations
2007 Revenue $9.2 - $9.3 billion Adjusted Operating Income — $1.5 - $1.6 billion % Margin 17% Adjusted EPS uate FAS 123R) $2.27 - $2.37 Operating Cash Flow Over $1 billion Eee eatbc adh tevave mcrae ase area ela tec eR Inebung afiSeoePs ardedustu oe tg icone, whee ect esricarig end oe ox Shicome ade
Slide 21: Longer-term Financial Goals
Longer-term Financial Goals Organic Revenue Growth 6-8% Adjusted Operating Margin 19 - 20% Adjusted EPS Growth 18 - 20% Tremendous Upside for Shareholders
Slide 22: Combination of complementary industry leaders
Combination of complementary industry leaders Strong track records “ Compelling financial benefits Delivering Enhanced Shareholder Value
Slide 23: Creating the Global Leader in the Life, Laboratory and Health Sciences Industry
Creating the Global Leader in the Life, Laboratory and Health Sciences Industry May 8, 2006
Fisher Scientific International — Merger or Acquisition (May 2006) on 6ix